参考文献/References:
[1] Grove BK,Kurer V,Lehner C,et al. A new 185,000-dalton skeletal muscle protein detected by monoclonal antibodies[J]. J Cell Biol,1984,98(2):518-524.
[2] Agarkova I,Auerbach D,Ehler E,et al. A novel marker for vertebrate embryonic heart,the EH-myomesin isoform[J]. J Biol Chem,2000,275(14):10256-10264.
[3] Masaki T,Takaiti O. M-protein[J]. J Biochem,1974,75(2):367-380.
[4] Schoenauer R,Lange S,Hirschy A,et al. Myomesin 3,a novel structural component of the M-band in striated muscle[J]. J Mol Biol,2008,376(2):338-351.
[5] Lange S,Pinotsis N,Agarkova I,et al. The M-band:the underestimated part of the sarcomere[J]. Biochim Biophys Acta Mol Cell Res,2020,1867(3):118440.
[6] Lange S,Himmel M,Auerbach D,et al. Dimerisation of myomesin:implications for the structure of the sarcomeric M-band[J]. J Mol Biol,2005,345(2):289-298.
[7] Pinotsis N,Lange S,Perriard JC,et al. Molecular basis of the C-terminal tail-to-tail assembly of the sarcomeric filament protein myomesin[J].Embo J,2008,27(1):253-264.
[8] Pernigo S,Fukuzawa A,Beedle AEM,et al. Binding of myomesin to obscurin-like-1 at the muscle m-band provides a strategy for isoform-specific mechanical protection[J]. Structure,2017,25(1):107-120.
[9] Fukuzawa A,Lange S,Holt M,et al. Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band:implications for hereditary myopathies[J]. J Cell Sci,2008,121(11):1841-1851.
[10] Schoenauer R,Bertoncini P,Machaidze G,et al. Myomesin is a molecular spring with adaptable elasticity[J]. J Mol Biol,2005,349(2):367-379.
[11] Pinotsis N,Chatziefthimiou SD,Berkemeier F,et al. Superhelical architecture of the myosin filament-linking protein myomesin with unusual elastic properties[J]. PLoS Biol,2012,10(2):e1001261.
[12] Reddy KB,Fox JE,Price MG,et al. Nuclear localization of Myomesin-1:possible functions[J]. J Muscle Res Cell Motil,2008,29(1):1-8.
[13] Wang X,Liu X,Wang S,et al. Myofibrillogenesis regulator 1 induces hypertrophy by promoting sarcomere organization in neonatal rat cardiomyocytes[J]. Hypertens Res,2012,35(6):597-603.
[14] Rullman E,Fernandez-Gonzalo R,Mekjavi? IB,et al. MEF2 as upstream regulator of the transcriptome signature in human skeletal muscle during unloading[J]. Am J Physiol Regul Integr Comp Physiol,2018,315(4):R799-R809.
[15] Kravchenko IV,Furalyov VA,Chatziefthimiou S,et al. Induction of insulin-like growth factor 1 splice forms by subfragments of myofibrillar proteins[J]. Mol Cell Endocrinol,2015,399:69-77.
[16] Kravchenko IV,Furalyov VA,Popov VO. Specific titin and myomesin domains stimulate myoblast proliferation[J]. Biochem Biophys Rep,2017,9:226-231.
[17] Obermann WM,van der Ven PF,Steiner F,et al. Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein,a structural protein of the sarcomeric M band[J]. Mol Biol Cell,1998,9(4):829-840.
[18] van der Ven PF,Furst DO. Assembly of titin,myomesin and M-protein into the sarcomeric M band in differentiating human skeletal muscle cells in vitro[J]. Cell Struct Funct,1997,22(1):163-171.
[19] Zuppinger C,Gibbons G,Dutta-Passecker P,et al. Characterization of cytoskeleton features and maturation status of cultured human iPSC-derived cardiomyocytes[J]. Eur J Histochem,2017,61(2):2763.
[20] Xu J,Gao J,Li J,et al. Functional analysis of slow myosin heavy chain 1 and myomesin-3 in sarcomere organization in zebrafish embryonic slow muscles[J]. J Genet Genomics,2012,39(2):69-80.
[21] Murphy S,Brinkmeier H,Krautwald M,et al. Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin[J]. J Muscle Res Cell Motil,2017,38(2):251-268.
[22] Koebis M,Ohsawa N,Kino Y,et al. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1[J]. Genes Cells,2011,16(9):961-972.
[23] Radke MH,Polack C,Methawasin M,et al. Deleting full length titin versus the titin M-band region leads to differential mechanosignaling and cardiac phenotypes[J]. Circulation,2019,139(15):1813-1827.
[24] Flix B,de la Torre C,Castillo J,et al. Dysferlin interacts with calsequestrin-1,myomesin-2 and dynein in human skeletal muscle[J]. Int J Biochem Cell Biol,2013,45(8):1927-1938.
[25] Hathout Y,Marathi RL,Rayavarapu S,et al. Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients[J]. Hum Mol Genet,2014,23(24):6458-6469.
[26] Rouillon J,Poupiot J,Zocevic A,et al. Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies[J]. Hum Mol Genet,2015,24(17):4916-4932.
[27] Schoenauer R,Emmert MY,Felley A,et al. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy[J]. Basic Res Cardiol,2011,106(2):233-247.
[28] Streckfuss-B?meke K,Tiburcy M,Fomin A,et al. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes[J]. J Mol Cell Cardiol,2017,113:9-21.
[29] Bollen IAE,Ehler E,Fleischanderl K,et al. Myofilament remodeling and function is more impaired in peripartum cardiomyopathy compared with dilated cardiomyopathy and ischemic heart disease[J]. Am J Pathol,2017,187(12):2645-2658.
[30] Shakeel M,Irfan M,Khan IA. Rare genetic mutations in Pakistani patients with dilated cardiomyopathy[J]. Gene,2018,673:134-139.
[31] Siegert R,Perrot A,Keller S,et al. A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties[J]. Biochem Biophys Res Commun,2011,405(3):473-479.